A Phase 2 Trial of Ponatinib in Philadelphia Chromosome–Positive Leukemias
Cortes, J.E, Kim, D.-W, Pinilla-Ibarz, J, le Coutre, P, Paquette, R, Chuah, C, Nicolini, F.E, Apperley, J.F, Khoury, H.J, Talpaz, M, DiPersio, J, DeAngelo, D.J, Abruzzese, E, Rea, D, Baccarani, M, Müller, M.C, Gambacorti-Passerini, C, Wong, S, Lustgarten, S, Rivera, V.M, Clackson, T, Turner, C.D, Haluska, F.G, Guilhot, F, Deininger, M.W, Hochhaus, A, Hughes, T, Goldman, J.M, Shah, N.P, Kantarjian, H
Published in The New England journal of medicine (07.11.2013)
Published in The New England journal of medicine (07.11.2013)
Get full text
Journal Article
Essential role of HDAC6 in the regulation of PD-L1 in melanoma
Lienlaf, M., Perez-Villarroel, P., Knox, T., Pabon, M., Sahakian, E., Powers, J., Woan, K.V., Lee, C., Cheng, F., Deng, S., Smalley, K.S.M., Montecino, M., Kozikowski, A., Pinilla-Ibarz, J., Sarnaik, A., Seto, E., Weber, J., Sotomayor, E.M., Villagra, A.
Published in Molecular oncology (01.05.2016)
Published in Molecular oncology (01.05.2016)
Get full text
Journal Article
Targeting histone deacetylase 6 mediates a dual anti-melanoma effect: Enhanced antitumor immunity and impaired cell proliferation
Woan, K.V., Lienlaf, M., Perez-Villaroel, P., Lee, C., Cheng, F., Knox, T., Woods, D.M., Barrios, K., Powers, J., Sahakian, E., Wang, H.W., Canales, J., Marante, D., Smalley, K.S.M., Bergman, J., Seto, E., Kozikowski, A., Pinilla-Ibarz, J., Sarnaik, A., Celis, E., Weber, J., Sotomayor, E.M., Villagra, A.
Published in Molecular oncology (01.08.2015)
Published in Molecular oncology (01.08.2015)
Get full text
Journal Article
P707: DOSE MODIFICATION DYNAMICS OF PONATINIB IN PATIENTS WITH CHRONIC‐PHASE CHRONIC MYELOID LEUKEMIA (CP‐CML) FROM THE PACE AND OPTIC TRIALS
Apperley, J., Kantarjian, H., Deininger, M., Abruzzese, E., Cortes, J., Chuah, C., DeAngelo, D. J., DiPersio, J., Hochhaus, A., Lipton, J., Nicolini, F., Pinilla‐Ibarz, J., Rea, D., Rosti, G., Rousselot, P., Mauro, M., Shah, N., Talpaz, M., Vorog, A., Ren, X., Jabbour, E.
Published in HemaSphere (01.06.2022)
Published in HemaSphere (01.06.2022)
Get full text
Journal Article
Nilotinib in imatinib-resistant or imatinib-intolerant patients with chronic myeloid leukemia in chronic phase: 48-month follow-up results of a phase II study
Giles, F J, le Coutre, P D, Pinilla-Ibarz, J, Larson, R A, Gattermann, N, Ottmann, O G, Hochhaus, A, Radich, J P, Saglio, G, Hughes, T P, Martinelli, G, Kim, D-W, Novick, S, Gillis, K, Fan, X, Cortes, J, Baccarani, M, Kantarjian, H M
Published in Leukemia (01.01.2013)
Published in Leukemia (01.01.2013)
Get full text
Journal Article
Clonal expansion of T NK-cells during tyrosine kinase inhibitor dasatinib therapy
Mustjoki, S, Ekblom, M, Arstila, T P, Dybedal, I, Epling-Burnette, P K, Guilhot, F, Hjorth-Hansen, H, Höglund, M, Kovanen, P, Laurinolli, T, Liesveld, J, Paquette, R, Pinilla-Ibarz, J, Rauhala, A, Shah, N, Simonsson, B, Sinisalo, M, Steegmann, J L, Stenke, L, Porkka, K
Published in Leukemia (01.08.2009)
Published in Leukemia (01.08.2009)
Get full text
Journal Article
FIRST RESULTS OF A HEAD‐TO‐HEAD TRIAL OF ACALABRUTINIB VERSUS IBRUTINIB IN PREVIOUSLY TREATED CHRONIC LYMPHOCYTIC LEUKEMIA
Hillmen, P., Byrd, J. C., Ghia, P., Kater, A. P., Chanan‐Khan, A., Furman, R. R., O'Brien, S., Yenerel, M. N., Illes, A., Kay, N., Garcia‐Marco, J. A., Mato, A., Pinilla‐Ibarz, J., Seymour, J. F., Lepretre, S., Stilgenbauer, S., Robak, T., Patel, P., Higgins, K., Sohoni, S., Jurczak, W.
Published in Hematological oncology (01.06.2021)
Published in Hematological oncology (01.06.2021)
Get full text
Journal Article
776: Inhibition of the IRE-1/XBP-1 pathway synergizes with ibrutinib for the treatment of B cell cancer
Tang, C.H, Ranatunga, S, Kriss, C, Cubitt, C, Tao, J, Pinilla-Ibarz, J, Del Valle, J, Hu, C.C
Published in European journal of cancer (1990) (01.07.2014)
Published in European journal of cancer (1990) (01.07.2014)
Get full text
Journal Article
Improved human T-cell responses against synthetic HLA-0201 analog peptides derived from the WT1 oncoprotein
PINILLA-IBARZ, J, MAY, R. J, KORONTSVIT, T, GOMEZ, M, KAPPEL, B, ZAKHALEVA, V, ZHANG, R. H, SCHEINBERG, D. A
Published in Leukemia (01.11.2006)
Published in Leukemia (01.11.2006)
Get full text
Journal Article
Vaccination of patients with chronic myelogenous leukemia with bcr-abl oncogene breakpoint fusion peptides generates specific immune responses
Pinilla-Ibarz, J., Cathcart, K., Korontsvit, T., Soignet, S., Bocchia, M., Caggiano, J., Lai, L., Jimenez, J., Kolitz, J., Scheinberg, D.A.
Published in Blood (01.03.2000)
Published in Blood (01.03.2000)
Get full text
Journal Article
FIXED‐DURATION VENETOCLAX PLUS OBINUTUZUMAB IMPROVES PFS AND MINIMAL RESIDUAL DISEASE NEGATIVITY IN PATIENTS WITH PREVIOUSLY UNTREATED CLL AND COMORBIDITIES
Fischer, K., Porro Lurà, M., Al‐Sawaf, O., Bahlo, J., Fink, A., Tandon, M., Dixon, M., Robrecht, S., Warburton, S., Humphrey, K., Samoylova, O., Liberati, A.M., Pinilla‐Ibarz, J., Opat, S., Sivcheva, L., Le Dû, K., Fogliatto, L.M., Utoft Niemann, C., Weinkove, R., Robinson, S., Kipps, T.J., Boettcher, S., Tausch, E., Schary, W.L., Eichhorst, B., Wendtner, C., Langerak, A.W., Kreuzer, K., Goede, V., Stilgenbauer, S., Mobasher, M., Ritgen, M., Hallek, M.
Published in Hematological oncology (01.06.2019)
Published in Hematological oncology (01.06.2019)
Get full text
Journal Article
Prediction of outcomes in patients with Ph+ chronic myeloid leukemia in chronic phase treated with nilotinib after imatinib resistance/intolerance
Jabbour, E, le Coutre, P D, Cortes, J, Giles, F, Bhalla, K N, Pinilla-Ibarz, J, Larson, R A, Gattermann, N, Ottmann, O G, Hochhaus, A, Hughes, T P, Saglio, G, Radich, J P, Kim, D-W, Martinelli, G, Reynolds, J, Woodman, R C, Baccarani, M, Kantarjian, H M
Published in Leukemia (01.04.2013)
Published in Leukemia (01.04.2013)
Get full text
Journal Article
A pilot vaccination trial of synthetic analog peptides derived from the BCR-ABL breakpoints in CML patients with minimal disease
Maslak, P G, Dao, T, Gomez, M, Chanel, S, Packin, J, Korontsvit, T, Zakhaleva, V, Pinilla-Ibarz, J, Berman, E, Scheinberg, D A
Published in Leukemia (01.08.2008)
Published in Leukemia (01.08.2008)
Get full text
Journal Article
Histone deacetylase 11 (HDAC11) is critical for plasma cell development and multiple myeloma survival
Brayer, J, Sahakian, E, Nguyen, D, Powers, J, Meads, M, Deng, S, Distler, A, Alsina, M, Nishihori, T, Baz, R, Villagra, A, Pinilla-Ibarz, J, Sotomayor, E.M, Shain, K
Published in Clinical lymphoma, myeloma and leukemia (01.09.2015)
Published in Clinical lymphoma, myeloma and leukemia (01.09.2015)
Get full text
Journal Article
P-100 Validation of the Revised International Prognostic Scoring System (IPSS-R) and its therapeutic implications
Mishra, A, Corrales-Yepez, M, Al-Ali, N, Kharfan-Dabaja, M, Padron, E, Zhang, L, Epling-Burnette, P, Pinilla-Ibarz, J, Lancet, J.E, List, A.F, Komrokji, R.S
Published in Leukemia research (01.05.2013)
Published in Leukemia research (01.05.2013)
Get full text
Journal Article
Venetoclax and Obinutuzumab in Patients with CLL and Coexisting Conditions
Fischer, Kirsten, Al-Sawaf, Othman, Bahlo, Jasmin, Fink, Anna-Maria, Tandon, Maneesh, Dixon, Mark, Robrecht, Sandra, Warburton, Simon, Humphrey, Kathryn, Samoylova, Olga, Liberati, Anna M, Pinilla-Ibarz, Javier, Opat, Stephen, Sivcheva, Liliya, Le Dû, Katell, Fogliatto, Laura M, Niemann, Carsten U, Weinkove, Robert, Robinson, Sue, Kipps, Thomas J, Boettcher, Sebastian, Tausch, Eugen, Humerickhouse, Rod, Eichhorst, Barbara, Wendtner, Clemens-Martin, Langerak, Anton W, Kreuzer, Karl-Anton, Ritgen, Matthias, Goede, Valentin, Stilgenbauer, Stephan, Mobasher, Mehrdad, Hallek, Michael
Published in The New England journal of medicine (06.06.2019)
Published in The New England journal of medicine (06.06.2019)
Get full text
Journal Article
A multivalent bcr-abl fusion peptide vaccination trial in patients with chronic myeloid leukemia
Cathcart, Kathleen, Pinilla-Ibarz, Javier, Korontsvit, Tatyana, Schwartz, Joseph, Zakhaleva, Victoriya, Papadopoulos, Esperanza B., Scheinberg, David A.
Published in Blood (01.02.2004)
Published in Blood (01.02.2004)
Get full text
Journal Article